SynthesisCardiovascular diabetology2022

Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6.

Mansoor Husain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.